Home Life Sciences N-homocysteinylation of apolipoprotein A-I impairs the protein’s antioxidant ability but not its cholesterol efflux capacity
Article
Licensed
Unlicensed Requires Authentication

N-homocysteinylation of apolipoprotein A-I impairs the protein’s antioxidant ability but not its cholesterol efflux capacity

  • Akari Miyazaki , Nozomi Sagae , Yoko Usami , Megumi Sato , Takahiro Kameda , Akira Yoshimoto , Nau Ishimine , Kazuyuki Matsuda , Mitsutoshi Sugano , Masayuki Hara , Takayuki Honda and Minoru Tozuka EMAIL logo
Published/Copyright: February 14, 2014

Abstract

A high homocysteine (Hcy) level is a risk factor for atherosclerosis. Hcy can be added to proteins through a process known as N-homocysteinylation. This is thought to be a potential cause of atherosclerosis induction. We previously reported that N-homocysteinylated apolipoprotein A-I (N-Hcy-apoA-I) was identified in normal human plasma. In this study, the effect of N-homocysteinylation on the functions of apoA-I was examined. A kinetic study using dimyristoyl phosphatidylcholine (DMPC) liposomes indicated that N-Hcy-apoA-I showed increased lipid-binding activity compared to wild-type apoA-I. Two reconstituted high-density lipoprotein (rHDL) particles of different sizes (approximately 8.2 nm and 7.6 nm in diameter) were produced by mixing apoA-I and 1-palmitoyl-2-oleoyl phosphatidylcholine (POPC). However, an increased ratio of large to small particles was found in rHDL prepared with N-Hcy-apoA-I. The normal apoA-I antioxidant ability, estimated by the suppression of conjugated diene formation in low-density lipoprotein (LDL) induced by copper sulfate oxidation, was considerably impaired when using N-Hcy-apoA-I. Although N-Hcy-apoA-I functioned as an oxidant, no significant difference was observed in the cholesterol efflux capacity from THP-1 macrophages between wild-type apoA-I and N-Hcy-apoA-I. These results suggest that N-Hcy-apoA-I might be proatherogenic due to its oxidative behavior but not an attenuation of cholesterol efflux capacity.


Corresponding author: Minoru Tozuka, Analytical Laboratory Chemistry, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan, e-mail:

Acknowledgments

We thank Professor Tetsuo Kubota (Microbiology and Immunology, Graduate School of Health Care Sciences, Tokyo Medical and Dental University) for generously assisting our collaborators. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 21590611).

References

Andersen, C.J., Blesso, C.N., Lee, J., Barona, J., Shah, D., Thomas, M.J., and Femandez, M.L. (2013). Egg consumption modulates HDL lipid composition and increases the cholesterol-accepting capacity of serum in metabolic syndrome. Lipids 48, 557–567.10.1007/s11745-013-3780-8Search in Google Scholar

Bhat, S., Sorci-Thomas, M.G., Calabresi, L., Samuel, M.P., and Thomas, M.J. (2010). Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles. Biochemistry 49, 5213–5224.10.1021/bi1003734Search in Google Scholar

Bielicki, J.K. and Oda, M.N. (2002). Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. Biochemistry 41, 2089–2096.10.1021/bi011716pSearch in Google Scholar

Calabresi, L., Vecchio, G., Frigerio, F., Vavassori, L., Sirton, C.R., and Franceschini, G. (1997). Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity. Biochemistry 36, 12428–12433.10.1021/bi970505aSearch in Google Scholar

Chiesa, G. and Sirtori, C.R. (2003). Apolipoprotein A-I(Milano): current perspectives. Curr. Opin. Lipidol. 14, 159–163.10.1097/00041433-200304000-00007Search in Google Scholar

Dionisio, N., Jardin, I., Salido, G.M., and Rosado, J.A. (2010). Homocysteine, intracellular signaling and thrombotic disorders. Curr. Med. Chem. 17, 3109–3119.10.2174/092986710791959783Search in Google Scholar

Ellman, G.L. (1959). Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70–77.10.1016/0003-9861(59)90090-6Search in Google Scholar

Gieseg, S.P. and Esterbauer, H. (1994). Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett. 343, 188–194.10.1016/0014-5793(94)80553-9Search in Google Scholar

Gillotte, K.L., Zaiou, M., Lund-Katz, S., Anantharamaiah, G.M., Holvoet, P., Dhoest, A., Palgunachari, M.N., Segrest, J.P., Weisgraber, K.H., Rothblat, G.H., et al. (1999). Apolipoprotein-mediated plasma membrane microsolubilization: role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipids. J. Biol. Chem. 274, 2021–2028.10.1074/jbc.274.4.2021Search in Google Scholar

Heinecke, J.W., Kawamura, M., Suzuki, L., and Chait, A. (1993). Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanism. J. Lipid Res. 34, 2051–2061.10.1016/S0022-2275(20)35347-5Search in Google Scholar

Ishibashi, M., Filomenko, R., Rébé, C., Chevriaux, A., Varin, A., Derangère, V., Bessède, G., Gambert, P., Lagrost, L., and Masson, D. (2013). Knock-down of the oxsterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation. Biochem. Pharmacol. 86, 122–129.10.1016/j.bcp.2012.12.024Search in Google Scholar

Ishimine, N., Usami, Y., Nogi, S., Sumida, T., Kurihara, Y., Matsuda, K., Nakamura, K., Yamauchi, K., Okumura, N., and Tozuka, M. (2010). Identification of N-homocysteinylated apolipoprotein AI in normal human serum. Ann. Clin. Biochem. 47, 453–459.10.1258/acb.2010.010035Search in Google Scholar

Jakubowski, H. (1997). Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 272, 1935–1942.10.1016/S0021-9258(19)67504-6Search in Google Scholar

Jakubowski, H. (2002). Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J. Biol. Chem. 277, 30425–30428.10.1074/jbc.C200267200Search in Google Scholar

Jakubowski, H. (2008). The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. Physiol. Pharmacol. Suppl. 9, 155–167.Search in Google Scholar

Jonas, A. (1986). Reconstitution of high-density lipoproteins. Methods Enzymol. 128, 553–582.10.1016/0076-6879(86)28092-1Search in Google Scholar

Julve, J., Escolà-Gil, J.C., Rodríguez-Millán, E., Martín-Campos, J.M., Jauhiainen, M., Quesada, H., Rentería-Obregón, I.M., Osada, J., Sánchez-Quesada, J.L., and Blanco-Vaca, F. (2013). Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport. Mol. Nutr. Food Res. 57, 1814–1824.10.1002/mnfr.201300133Search in Google Scholar PubMed

Kameda, T., Usami, Y., Shimada, S., Haraguchi, G., Matsuda, K., Sugano, M., Kurihara, Y., Isobe, M., and Tozuka, M. (2012). Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein. Ann. Clin. Lab. Sci. 42, 384–391.Search in Google Scholar

Larrede, S., Quinn, C.M., Jessup, W., Frisdal, E., Olivier, M., Hsieh, V., Kim M.J., Van Eck, M., Couvert, P., Carrie, A., et al. (2009). Stimulation of cholesterol efflux by LXR agonist in cholesterol-loaded human macrophages is ABCA1-dependent but not ABCG1-indipendent. Arterioscler. Thromb. Vasc. Biol. 29, 1930–1936.10.1161/ATVBAHA.109.194548Search in Google Scholar PubMed

Lentz, S.R. (2001). Does homocysteine promote atherosclerosis? Arterioscler. Thromb. Vasc. Biol. 22, 1385–1386.10.1161/atvb.21.9.1385Search in Google Scholar

Meng, S., Ciment, S., Jan, M., Tran, T., Pham, H., Cueto, R., Yang, X-F., and Wang, H. (2013). Homocysteine induces inflammatory transcriptional signaling in monocytes. Front Biosci. 18, 685–695.10.2741/4131Search in Google Scholar PubMed PubMed Central

Wang, X., Cui, L., Joseph, J., Jiang, B., Pimental, D., Handy, D.E., Liao, R., and Loscalzo, J. (2012). Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J. Mol. Cell Cardiol. 52, 753–760.10.1016/j.yjmcc.2011.12.009Search in Google Scholar PubMed PubMed Central

Weisgraber, K.H., Rall, S.C. Jr, Bersot, T.P., Mahley, R.W., Franceschini, G., and Sirtori, C.R. (1983). Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J. Biol. Chem. 258, 2508–2513.10.1016/S0021-9258(18)32955-7Search in Google Scholar

Zhu, X., Wu, G., Zeng, W., Xue, H., and Chen, B. (2005). Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties. J. Lipid Res. 46, 1303–1311.10.1194/jlr.M400401-JLR200Search in Google Scholar PubMed

Received: 2013-9-29
Accepted: 2014-2-10
Published Online: 2014-2-14
Published in Print: 2014-6-1

©2014 by Walter de Gruyter Berlin/Boston

Downloaded on 8.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/hsz-2013-0262/html
Scroll to top button